Sinil Pharmaceutical Co. Ltd (012790) — Free Cash Flow Generation Index
Sinil Pharmaceutical Co. Ltd (012790) has a Free Cash Flow Generation Index of 0.92x as of September 2025. Free cash flow of ₩2.41 Billion represents 1% of operating cash flow (₩2.62 Billion). Read debt load of Sinil Pharmaceutical Co. Ltd for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sinil Pharmaceutical Co. Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for Sinil Pharmaceutical Co. Ltd across 11 annual periods. Explore reinvestment intensity of Sinil Pharmaceutical Co. Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Sinil Pharmaceutical Co. Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for Sinil Pharmaceutical Co. Ltd. For the full company profile including market capitalisation, see market cap of Sinil Pharmaceutical Co. Ltd.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.63x | ₩14.22 Billion | ₩22.69 Billion | ₩8.47 Billion | ▲ +325.2% |
| 2023 | 0.15x | ₩2.23 Billion | ₩15.15 Billion | ₩12.92 Billion | ▼ -53.7% |
| 2022 | 0.32x | ₩4.36 Billion | ₩13.69 Billion | ₩9.33 Billion | ▼ -52.8% |
| 2021 | 0.67x | ₩7.53 Billion | ₩11.16 Billion | ₩3.63 Billion | ▲ +188.2% |
| 2020 | 0.23x | ₩2.59 Billion | ₩11.06 Billion | ₩8.80 Billion | ▼ -66.6% |
| 2019 | 0.70x | ₩8.63 Billion | ₩12.31 Billion | ₩9.73 Billion | ▼ -63.2% |
| 2018 | 1.91x | ₩17.53 Billion | ₩9.19 Billion | ₩8.33 Billion | ▼ -8.4% |
| 2017 | 2.08x | ₩18.05 Billion | ₩8.67 Billion | ₩9.38 Billion | ▲ +71.7% |
| 2016 | 1.21x | ₩14.66 Billion | ₩12.09 Billion | ₩2.57 Billion | ▼ -24.5% |
| 2015 | 1.61x | ₩15.37 Billion | ₩9.56 Billion | ₩5.80 Billion | ▲ +29.6% |
| 2014 | 1.24x | ₩11.57 Billion | ₩9.33 Billion | ₩2.24 Billion | — |